DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,515,000 | +48.7% | 40,584 | +1.8% | 0.00% | 0.0% |
Q1 2021 | $1,019,000 | +365.3% | 39,865 | +301.2% | 0.00% | – |
Q4 2020 | $219,000 | -40.2% | 9,937 | -40.2% | 0.00% | – |
Q4 2019 | $366,000 | -81.8% | 16,618 | -88.1% | 0.00% | -100.0% |
Q3 2019 | $2,006,000 | -34.5% | 139,683 | -28.2% | 0.00% | -33.3% |
Q2 2019 | $3,064,000 | – | 194,530 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |